ATARA BIOTHERAPEUTICS, INC. (ATRA) Net income 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$32.7MFY2025 · since FY2016: -$79.0M → $32.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $32.7M | +138.3% |
| FY2024 | -$85.4M | +69.1% |
| FY2023 | -$276.1M | -20.9% |
| FY2022 | -$228.3M | +32.9% |
| FY2021 | -$340.1M | -10.9% |
| FY2020 | -$306.6M | -5.4% |
| FY2019 | -$291.0M | -26.1% |
| FY2018 | -$230.7M | -93.1% |
| FY2017 | -$119.5M | -51.2% |
| FY2016 | -$79.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATRA financial trends
ATRA RevenueATRA Net marginATRA Gross profitATRA Gross marginATRA Operating incomeATRA Operating marginATRA Operating cash flowATRA Free cash flowATRA Capital expendituresATRA Return on equityATRA Stock buybacksATRA Dividends paidATRA Total assetsATRA Total liabilitiesATRA Shareholders’ equityATRA overview →